Medicines Co. (MDCO) Agrees to be Acquired by Novartis AG (NVS) for $9.7B, or $85/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. META
2. OKTA
3. ORCL
4. SPY
5. P
6. NVDA
7. MCD
8. MGM
9. GDDY
10. ACAD

Go back to Medicines Co. (MDCO) Agrees to be Acquired by Novartis AG (NVS) for $9.7B, or $85/Share

The Medicines Company Enters Into Definitive Agreement to be Acquired by Novartis AG for $9.7 Billion

November 24, 2019 3:05 PM EST

- The Medicines Company to be acquired by Novartis AG for $85 per share in cash, representing 45% premium to its unaffected share price and a 57% premium to its unaffected one-week average price

- Inclisiran, The Medicines Companys investigational, innovative, potent twice-annual therapy to lower LDL cholesterol, has potential to transform treatment of cardiovascular disease

- Transaction expected to be completed in first quarter of 2020

PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ: MDCO) announced today that it has entered into definitive agreement in which Novartis AG will... More